Labcorp (LH) Competitors

Labcorp (NYSE:LH) and Hologic (NASDAQ:HOLX) are both large-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, risk, analyst recommendations, dividends, profitability, valuation, institutional ownership and earnings.

Do insiders & institutionals hold more shares of LH or HOLX?

95.9% of Labcorp shares are owned by institutional investors. Comparatively, 94.7% of Hologic shares are owned by institutional investors. 0.8% of Labcorp shares are owned by insiders. Comparatively, 1.9% of Hologic shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Is LH or HOLX more profitable?

Hologic has a net margin of 13.79% compared to Labcorp's net margin of 5.66%. Hologic's return on equity of 19.69% beat Labcorp's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Labcorp	5.66%	15.45%	7.02%
Hologic	13.79%	19.69%	10.82%

Which has stronger valuation & earnings, LH or HOLX?

Hologic has lower revenue, but higher earnings than Labcorp. Hologic is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Labcorp	$13.01B	1.77	$746M	$9.06	30.59
Hologic	$4.03B	3.64	$789.50M	$2.41	27.39

Do analysts prefer LH or HOLX?

Labcorp presently has a consensus target price of $290.33, suggesting a potential upside of 4.76%. Hologic has a consensus target price of $78.00, suggesting a potential upside of 18.18%. Given Hologic's higher possible upside, analysts plainly believe Hologic is more favorable than Labcorp.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Labcorp	1 Sell rating(s)	3 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.62
Hologic	0 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.59

Which has more risk and volatility, LH or HOLX?

Labcorp has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, Hologic has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500.

Does the media prefer LH or HOLX?

In the previous week, Hologic had 4 more articles in the media than Labcorp. MarketBeat recorded 22 mentions for Hologic and 18 mentions for Labcorp. Labcorp's average media sentiment score of 1.57 beat Hologic's score of 1.40 indicating that Labcorp is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Labcorp	17 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Hologic	17 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Hologic beats Labcorp on 9 of the 17 factors compared between the two stocks.